Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Down Syndrome

fluorodeoxyglucose f18 has been researched along with Down Syndrome in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19904 (26.67)18.7374
1990's3 (20.00)18.2507
2000's4 (26.67)29.6817
2010's3 (20.00)24.3611
2020's1 (6.67)2.80

Authors

AuthorsStudies
Alcolea, D; Altuna, M; Annus, T; Barroeta, I; Belbin, O; Benejam, B; Blesa, R; Camacho, V; Carmona-Iragui, M; Clarimón, J; Estellés, T; Fernández, S; Fortea, J; Giménez, S; González-Ortiz, S; Holland, AJ; Illán-Gala, I; Lehmann, S; Lleó, A; Montal, V; Muñoz, L; Osorio, RS; Pegueroles, J; Valldeneu, S; Videla, L; Videla, S; Vilaplana, E; Wilson, LR; Zaman, SH1
Andrews, RD; Brewer, J; Lukic, AS; Matthews, DC; Mobley, WC; Ness, S; Pennington, C; Rafii, MS; Rissman, RA; Strother, SC; Wernick, MN1
Barnhart, TE; Betthauser, TJ; Bulova, PD; Christian, BT; Cohen, AD; Devenny, DA; Handen, BL; Hartley, SL; Johnson, SC; Klunk, WE; Lao, PJ; Lopresti, BJ; Mathis, CA; Mihaila, I; Murali, D; Price, JC; Stone, CK; Tudorascu, DL; Tumuluru, RV1
Bandy, D; Belden, C; Chen, K; Fleisher, AS; Jacobson, S; Liebsack, C; Liu, X; Luo, J; Malek-Ahmadi, M; Powell, J; Protas, H; Reiman, EM; Rogers, J; Roontiva, A; Sabbagh, MN; Thiyyagura, P1
Alkire, MT; Cotman, CW; Haier, RJ; Head, E; Lott, IT; Uncapher, MR; White, NS1
Balogh, E; Emri, M; Esik, O; Kollár, J; Lengyel, Z; Oláh, E; Sikula, J; Szikszai, E; Trón, L2
Creasey, H; Cutler, NR; Duara, R; Grady, CL; Haxby, JV; Rapoport, SI; Schapiro, MB1
Alexander, GE; Dani, A; Freo, U; Furey, ML; Grady, CL; Haxby, JV; Horwitz, B; Mangot, D; Mentis, MJ; Pietrini, P; Schapiro, MB; Simon, EW1
Comblain, A; Rondal, JA1
Friedland, RP; Grady, CL; Haxby, JV; Herscovitch, P; Kumar, A; Moore, AM; Rapoport, SI; Schapiro, MB; White, B1
Grady, CL; Horwitz, B; Rapoport, SI; Schapiro, MB1
Cutler, NR; Davies, P; Haxby, JV; Heston, LL; Schapiro, MB1
Cutler, NR1
Duara, R; Grady, CL; Haxby, JV; Larson, SM; Moore, A; Rapoport, SI; Schapiro, MB; Schlageter, NL; Sundaram, M; White, B1

Reviews

1 review(s) available for fluorodeoxyglucose f18 and Down Syndrome

ArticleYear
NIH Conference. Alzheimer's disease and Down's syndrome: new insights.
    Annals of internal medicine, 1985, Volume: 103, Issue:4

    Topics: Adult; Age Factors; Aged; Alzheimer Disease; Brain; Brain Chemistry; Cognition; Dementia; Deoxyglucose; Down Syndrome; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Memory; Middle Aged; Neurotransmitter Agents; Parasympathetic Nervous System; Psychological Tests; Tomography, Emission-Computed

1985

Trials

1 trial(s) available for fluorodeoxyglucose f18 and Down Syndrome

ArticleYear
Temporal cortex hypermetabolism in Down syndrome prior to the onset of dementia.
    Neurology, 2003, Dec-23, Volume: 61, Issue:12

    Topics: Adult; Aged; Alzheimer Disease; Down Syndrome; Entorhinal Cortex; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Gyrus Cinguli; Humans; Male; Middle Aged; Neuropsychological Tests; Reference Values; Reproducibility of Results; Temporal Lobe; Tomography, Emission-Computed

2003

Other Studies

13 other study(ies) available for fluorodeoxyglucose f18 and Down Syndrome

ArticleYear
Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
    Lancet (London, England), 2020, 06-27, Volume: 395, Issue:10242

    Topics: Adult; Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Apolipoproteins E; Biomarkers; Case-Control Studies; Cognitive Dysfunction; Cross-Sectional Studies; Down Syndrome; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neurofilament Proteins; Positron-Emission Tomography; Prevalence; Spain; tau Proteins; United Kingdom

2020
PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI).
    Journal of Alzheimer's disease : JAD, 2017, Volume: 60, Issue:2

    Topics: Adult; Amyloid; Apolipoproteins E; Cerebellum; Cognition Disorders; Cohort Studies; Down Syndrome; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; tau Proteins

2017
Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome.
    Journal of Alzheimer's disease : JAD, 2018, Volume: 61, Issue:2

    Topics: Adult; Alzheimer Disease; Amyloid beta-Peptides; Down Syndrome; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Linear Models; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; United States

2018
Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia.
    Alzheimer's & dementia : the journal of the Alzheimer's Association, 2015, Volume: 11, Issue:8

    Topics: Adult; Alzheimer Disease; Aniline Compounds; Brain; Down Syndrome; Emergency Services, Psychiatric; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography

2015
Pattern of increased cerebral FDG uptake in Down syndrome patients.
    Pediatric neurology, 2006, Volume: 34, Issue:4

    Topics: Adolescent; Adult; Case-Control Studies; Child; Child, Preschool; Down Syndrome; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Rest; Telencephalon

2006
NIH Conference. Brain imaging: aging and dementia.
    Annals of internal medicine, 1984, Volume: 101, Issue:3

    Topics: Adult; Aged; Aging; Alzheimer Disease; Brain; Deoxyglucose; Down Syndrome; Female; Fluorine; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mental Processes; Middle Aged; Radioisotopes; Tomography, Emission-Computed; Tomography, X-Ray Computed; Wechsler Scales

1984
Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
    The American journal of psychiatry, 1997, Volume: 154, Issue:8

    Topics: Acoustic Stimulation; Adult; Age Factors; Alzheimer Disease; Auditory Perception; Brain; Deoxyglucose; Down Syndrome; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Motion Pictures; Parietal Lobe; Photic Stimulation; Risk Factors; Temporal Lobe; Tomography, Emission-Computed; Visual Perception

1997
Language in ageing persons with Down syndrome.
    Down's syndrome, research and practice : the journal of the Sarah Duffen Centre, 2002, Volume: 8, Issue:1

    Topics: Adolescent; Adult; Age Factors; Brain; Cohort Studies; Cross-Sectional Studies; Down Syndrome; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Language Development Disorders; Language Tests; Longitudinal Studies; Male; Middle Aged; Tomography, Emission-Computed

2002
[Cerebral glucose metabolism in Down syndrome using positron emission tomography].
    Orvosi hetilap, 2002, May-26, Volume: 143, Issue:21 Suppl 3

    Topics: Adolescent; Adult; Brain; Child; Child, Preschool; Down Syndrome; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed

2002
Regional cerebral glucose metabolism is normal in young adults with Down syndrome.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 1990, Volume: 10, Issue:2

    Topics: Adult; Aging; Brain; Deoxyglucose; Down Syndrome; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Reference Values; Tomography, Emission-Computed

1990
Cerebral metabolic pattern in young adult Down's syndrome subjects: altered intercorrelations between regional rates of glucose utilization.
    Journal of mental deficiency research, 1990, Volume: 34 ( Pt 3)

    Topics: Adult; Blood Glucose; Brain; Brain Mapping; Cerebral Cortex; Deoxyglucose; Dominance, Cerebral; Down Syndrome; Female; Fluorodeoxyglucose F18; Humans; Male; Tomography, Emission-Computed

1990
Cerebral metabolism as measured with positron emission tomography (PET) and [18F] 2-deoxy-D-glucose: healthy aging, Alzheimer's disease and Down syndrome.
    Progress in neuro-psychopharmacology & biological psychiatry, 1986, Volume: 10, Issue:3-5

    Topics: Aging; Alzheimer Disease; Brain; Deoxyglucose; Down Syndrome; Fluorodeoxyglucose F18; Glucose; Humans; Memory; Oxygen Consumption; Radioisotopes; Tomography, Emission-Computed

1986
Decline in cerebral glucose utilisation and cognitive function with aging in Down's syndrome.
    Journal of neurology, neurosurgery, and psychiatry, 1987, Volume: 50, Issue:6

    Topics: Adolescent; Adult; Aging; Brain; Cognition; Deoxyglucose; Down Syndrome; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Tomography, Emission-Computed

1987